SUMMARY -Breast cancer is the most frequently diagnosed cancer and the leading cause of death from cancer in women. Th e accuracy of diagnosis can be increased with a combination of clinical examination, imaging diagnostics, and fi ne needle aspiration cytology (FNAC) or core needle biopsy, also known as triple test. Th e aim of the study was to evaluate the sensitivity and specifi city of FNAC in the diagnosis of breast tumors in our institution by correlating it with histopathology fi ndings. We assessed the accuracy of 124 FNAC fi ndings by comparing cytological diagnosis of breast masses with the diagnoses from histopathology reports obtained by surgery. Statistical analysis showed 95.1% accuracy, 97.7% sensitivity, 89.1% specifi city, 95.5% positive predictive value and 94.2% negative predictive value of FNAC. Study results indicated that FNAC could be used as a highly reliable tool in the diff erential diagnosis of breast tumors, in combination with clinical and imaging fi ndings, especially in developing countries with limited fi nancial resources.
Introduction
Breast cancer is the most frequently diagnosed cancer and the leading cause of death from cancer in women. Breast cancer survival rates tend to be poorer in developing countries, most likely because of a combination of late diagnosis and limited access to timely and appropriate treatment 1 . Th e accuracy of diagnosis can be increased with a combination of clinical examination, imaging diagnostics, and fi ne needle aspiration cytology (FNAC) or core needle biopsy, also known as triple test 2 . FNAC is a minimally invasive, simple, cost-eff ective, safe and sensitive method for breast tumor diagnosis 3 . Many authors have shown that FNAC is highly accurate in the diagnosis of breast tumors 4, 5 .
Using the ultrasound guided method, FNAC has been used more widely for non-palpable breast tumors 6, 7 . Although core biopsy is preferred to FNAC in most developed countries, its procedure is more expensive and time consuming as compared to FNAC [8] [9] [10] . Th is study was conducted to evaluate the sensitivity and specifi city of FNAC in the diagnosis of breast tumors in our institution by correlating it with histopathology fi ndings.
Materials and Methods
Th is retrospective study was conducted at the Clinical Department of Pathology, Cytology and Forensic Medicine, Mostar University Hospital in Mostar, Bosnia and Herzegovina. Data were collected from the archives of our institution for women with breast masses having received FNA cytological diagnosis and histopathologic evaluation during the period from January 2012 to December 2013. We assessed the ac-curacy of FNA fi ndings by comparing cytological diagnoses of breast masses to the diagnoses from histopathology reports obtained by surgery. FNA was obtained through a 22-24-gauge needle; the aspirated content was then smeared on a glass slide, air-dried and stained with May-Grünwald-Giemsa for 30 min. Cytological diagnoses were classifi ed into 3 categories: benign, suspect and malignant. Benign category includes poor cellularity, good cohesion and fl at sheets of cells, and smooth or fi ne chromatin with no nuclear irregularity. Malignant category includes high cellularity, poor cohesion and three-dimensional arrangement of cells, clumped chromatin with variable nuclear size and pleomorphism. Suspect category should be used when the cytologist is almost certain that they come from a malignant lesion, although a confi dent diagnosis cannot be made.
Statistical analysis to determine sensitivity, specifi city, positive predictive value and negative predictive value with their 95% confi dence intervals was performed using the SPSS 13.0 for Windows statistical software (SPSS Inc., Chicago, Illinois, USA). All values were calculated for the benign and malignant groups only, and for the benign, malignant and suspect groups together. Th e suspect and malignant cases were grouped together, based on the assumption for suspect cases to be positive for malignancy.
Th e study was approved by the Ethics Committee of the Mostar University Hospital and in accordance with the Helsinki Declaration 11 .
Results
In this study, we collected 124 FNA diagnoses and histopathology reports. Median age was 46 (range 16-88) years. Out of 124 cases according to FNA, there were 35 (28.2%) benign, 83 (66.9%) malignant and 6 (4.8%) suspect cases. Out of the 85 confi rmed malignant cases, 80 cases were malignant on cytology, 5 cases were suspect of malignancy, and 2 cases were benign. Th ere were 3 benign cases confi rmed by histology which were classifi ed as malignant by cytology report (Table 1) . Th e most common causes of falsepositive cytological diagnosis were atypical lobular hyperplasia, papilloma and spreading artifacts. Th e most common cause of false-negative cytological diagnosis was inadequate aspiration. Table 2 summarizes data on the overall accuracy, sensitivity, specifi city, positive predictive value and negative predictive value of FNA.
Discussion
Accurate diagnosis of breast tumors can help avoid unnecessary surgical procedures and plan correct treatment options. Every patient with breast tumor should undergo triple test to make early and accurate diagnosis. FNA is widely used in the diff erential diagnosis of breast tumors because of the high level of accuracy, rapid results, and for being a less invasive procedure than tissue biopsy 12, 13 . Th e accuracy, sensitivity and specifi city found in our study showed FNA of breast tumors to be a reliable method for diff erential diagnosis of benign from malignant masses. Our study fi ndings are consistent with those reported in the literature 1,4,14 . We had 4.8% of suspect FNA diagnoses. Th ese fi ndings are in line with previous reports 15 . According to various studies, the false-positive rate ranges from 0 to 2.5%, which is slightly lower than 3.2% found in this study 4, 5, 15 . Th e false-negative rate in our study was 1.6%, which is lower in comparison to other . False-negative and false-positive results occur due to physician experience 16, 17 , sample quality 18 and certain histopathology diagnoses 19 . Using ultrasound guided FNAC increases specifi city and sensitivity of FNA 20, 21 . False-positive and false-negative results can mislead clinicians and therefore FNA should not be used as the only diagnostic tool in diff erential diagnosis of breast tumors. Results of FNAC should be interpreted in correlation to clinical and imaging fi ndings, thus reducing the risk of missed diagnosis of breast cancer [22] [23] [24] . Even though diagnostic accuracy of core needle biopsy and FNA is similar 24 , many physicians prefer core needle biopsy as a technique superior to FNA because core needle biopsy can better detect ductal carcinoma in situ and off ers better histopathologic and immunohistochemical evaluation of tumor tissues 25, 26 . Evaluation of estrogen receptor can also be done in cytologic material, which is favorable for some patients, particularly those undergoing preoperative chemotherapy or irradiation, or those with inoperable primary tumor [27] [28] [29] . Because FNA is less traumatic and easier technique than core needle biopsy, it can be repeated in the same day in case of unsatisfactory samples. FNA is cost-eff ective even when followed by core needle biopsy or surgical excision 8 . Th erefore, it is possible to introduce FNA procedure into smaller hospitals where physicians are less experienced with this technique 30, 31 . Th is study indicated that FNA could be used as a highly reliable tool, in combination with clinical and imaging fi ndings, in the diff erential diagnosis of breast tumors, especially in developing countries with limited fi nancial resources.
Conclusion
Th is study indicated FNA to be an accurate and highly reliable tool in the assessment of breast tumors. With high sensitivity and specifi city, most breast tumors can be reliably diagnosed by FNA. It is a simple, safe, cost-eff ective and accurate method for the initial diagnosis and for guiding treatment. However, one must be aware of the possibility of false-positive and false-negative results. All patients with breast tumors should be diagnosed based on a combination of physical examination, radiological diagnostics and FNA. FNA is an acceptable and reliable procedure for the preoperative diagnosis of breast tumors, particularly in developing countries.
